Axcella Health Inc.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is …
Biotechnology
US, Cambridge [HQ]
Balance Sheet
6 Sheets · Starting from 2017In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
| Assets | 48.00 | 81.00 | - - | - - | - - | - - | |
|
Current
|
47.00 | 80.00 | - - | - - | - - | - - | |
| Cash And Equivalents | 46.00 | 79.00 | - - | - - | - - | - - | |
| Assets | 48.00 | 81.00 | - - | - - | - - | - - | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | - - | - - | |
| Short Term Investments | - - | - - | - - | - - | - - | - - | |
| Other Current Assets | - - | - - | - - | - - | - - | - - | |
|
Non Current
|
1.00 | 1.00 | - - | - - | - - | - - | |
| Property, Plant, Equipment (Net) | 1.00 | 1.00 | - - | - - | - - | - - | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | - - | - - | - - | - - | - - | - - | |
| Liabilities | 165.00 | 33.00 | - - | - - | - - | - - | |
|
Current
|
5.00 | 6.00 | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | |
| Short Term Debt | - - | - - | - - | - - | - - | - - | |
| Deferred Revenue | - - | - - | - - | - - | - - | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 4.00 | 5.00 | - - | - - | - - | - - | |
|
Non Current
|
160.00 | 26.00 | - - | - - | - - | - - | |
| Long Term Debt | 19.00 | 24.00 | - - | - - | - - | - - | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | 140.00 | 1.00 | - - | - - | - - | - - | |
| Equity | - - | 48.00 | - - | - - | - - | - - | |
| Stockholders' Equity | -116.00 | 48.00 | - - | - - | - - | - - | |
| Retained Earnings | -120.00 | -157.00 | - - | - - | - - | - - | |
| Common Stock | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | |
| Profit | -30.00 | -36.00 | -59.00 | -58.00 | -67.00 | -81.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 146.00 | 7.00 | - - | - - | - - | - - | |
| Loss Other Compr. Income | -2.00 | -3.00 | - - | - - | - - | - - |